Understanding the risks for young mothers in child care proceedings

Mothers under the age of 20 are at the greatest risk of being involved in care proceedings in the 10 years after having their first child, finds a new study report led by UCL researchers.

Praxis’ epilepsy drug reduces seizures by 46% in pediatric patients in Phase 2 study

Praxis Precision Medicines released another batch of topline data from its epilepsy program on Tuesday, this time from the Phase 2 EMBOLD study investigating relutrigine

September 4, 2024

Biophytis and Innovation Solutions Pharma sign a partnership agreement to accelerate market access for Sarconeos (BIO101) in Brazil – Biotech Investments

Biophytis / Key word(s): Miscellaneous Biophytis and Innovation Solutions Pharma sign a partnership agreement to accelerate market access for Sarconeos (BIO101) in Brazil 30-Oct-2023 /

October 31, 2023

HIMSS22 Europe: ‘We need to develop eco-friendly digital health’

A shocking statistic was revealed at the session on ‘Climate Crisis: Healthcare’s Responsibility to Our Planet’ at the HIMSS22 European Conference on Thursday (16 June). According

June 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.